Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial

Lancet

Volumn 364, Issue 9444, 2004, Pages 1497-1504

  Homs, Marjolein Y V ^a   Steyerberg, Ewout W ^a   Eijkenboom, Wilhelmina M H ^a   Tilanus, Hugo W ^a   Stalpers, Lukas J A ^b   Bartelsman, Joep F W M ^b   Van Lanschot, Jan J B ^b   Wijrdeman, Harm K ^c   Mulder, Chris J J ^d   Reinders, Janny G ^e   Boot, Henk ^f   Aleman, Berthe M P ^f   Kuipers, Ernst J ^a   Siersema, Peter D ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e Arnhems Radiotherapeutisch Instituut   (Netherlands)

^f NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CARCINOMA; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NETHERLANDS; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SCORING SYSTEM; STENT; TREATMENT OUTCOME;

EID: 6944231389     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)17272-3     Document Type: Article

References (39)

1. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 37:(suppl 8):2001;S4-66
2. Botterweck AA, Schouten LJ, Volovics A, Dorant E, van Den Brandt PA. Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol. 29:2000;645-654
3. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053
4. Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer. 83:1999;18-29
5. Sundelof M, Ye W, Dickman PW, Lagergren J. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer. 99:2002;751-754
6. De Palma GD, Galloro G, Sivero L, et al. Self-expanding metal stents for palliation of inoperable carcinoma of the esophagus and gastroesophageal junction. Am J Gastroenterol. 90:1995;2140-2142
7. Siersema PD, Hop WC, van Blankenstein M, et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest Endosc. 54:2001;145-153
8. Kozarek RA, Raltz S, Brugge WR, et al. Prospective multicenter trial of esophageal Z-stent placement for malignant dysphagia and tracheoesophageal fistula. Gastrointest Endosc. 44:1996;562-567
9. Raijman I, Siddique I, Ajani J, Lynch P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest Endosc. 48:1998;172-179
10. Bartelsman JF, Bruno MJ, Jensema AJ, Haringsma J, Reeders JW, Tytgat GN. Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprosthesis: experiences in 153 patients. Gastrointest Endosc. 51:2000;134-138
11. Spencer GM, Thorpe SM, Blackman GM, et al. Laser augmented by brachytherapy versus laser alone in the palliation of adenocarcinoma of the oesophagus and cardia: a randomised study. Gut. 50:2002;224-227
12. Dallal HJ, Smith GD, Grieve DC, Ghosh S, Penman ID, Palmer KR. A randomized trial of thermal ablative therapy versus expandable metal stents in the palliative treatment of patients with esophageal carcinoma. Gastrointest Endosc. 54:2001;549-557
13. Taal BG, Aleman BM, Koning CC, Boot H. High dose rate brachytherapy before external beam irradiation in inoperable oesophageal cancer. Br J Cancer. 74:1996;1452-1457
14. Schraube P, Fritz P, Wannenmacher MF. Combined endoluminal and external irradiation of inoperable oesophageal carcinoma. Radiother Oncol. 44:1997;45-51
15. Homs MY, Eijkenboom WM, Coen VL, et al. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol. 66:2003;327-332
16. Brewster AE, Davidson SE, Makin WP, Stout R, Burt PA. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin Oncol (R Coll Radiol). 7:1995;102-105
17. Gaspar LE, Nag S, Herskovic A, Mantravadi R, Speiser B. American Brachytherapy Society (ABS) consensus guidelines for brachytherapy of esophageal cancer. Clinical Research Committee, American Brachytherapy Society, Philadelphia, PA. Int J Radiat Oncol Biol Phys. 38:1997;127-132
18. Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int J Radiat Oncol Biol Phys. 53:2002;127-133
19. Allum WH, Griffin SM, Watson A, Colin-Jones D. Guidelines for the management of oesophageal and gastric cancer. Gut. 50:(suppl 5):2002;v1-23
20. Blazeby JM. Measurement of outcome. Surg Oncol. 10:2001;127-133
21. Ogilvie AL, Dronfield MW, Ferguson R, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibreoptic endoscopy. Gut. 23:1982;1060-1067
22. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 85:1993;365-376
23. Blazeby JM, Alderson D, Winstone K, et al. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. The EORTC Quality of Life Study Group. Eur J Cancer. 32A:1996;1912-1917
24. Dolan P. Modeling valuations for EuroQol health states. Med Care. 35:1997;1095-1108
25. Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. 1996;Oxford University Press, New York
26. Jager J, Langendijk H, Pannebakker M, Rijken J, de Jong J. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother Oncol. 37:1995;237-240
27. Sur RK, Donde B, Levin VC, Mannell A. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced esophageal cancer. Int J Radiat Oncol Biol Phys. 40:1998;447-453
28. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 80:1988;1198-1202
29. Efron B, Tibshirani R. An introduction to the bootstrap. 1993;Chapman and Hall, New York
30. Fairclough DL. Design and analysis of quality of life studies in clinical trials. 2002;Chapman and Hall/CRC, Boca Raton
31. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ. 320:2000;1197-1200
32. Siersema PD, Tan TG, Sutorius FF, Dees J, van Blankenstein M. Massive hemorrhage caused by a perforating Gianturco-Z stent resulting in an aortoesophageal fistula. Endoscopy. 29:1997;416-420
33. Allgaier HP, Schwacha H, Technau K, Blum HE. Fatal esophagoaortic fistula after placement of a self-expanding metal stent in a patient with esophageal carcinoma. N Engl J Med. 337:1997;1778
34. Sur M, Sur R, Cooper K, Levin V, Bizos D, Dubazana N. Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy. Cancer. 77:1996;2200-2205
35. Siersema PD, Marcon N, Vakil N. Metal stents for tumors of the distal esophagus and gastric cardia. Endoscopy. 35:2003;79-85
36. Sabharwal T, Hamady MS, Chui S, Atkinson S, Mason R, Adam A. A randomised prospective comparison of the Flamingo Wallstent and Ultraflex stent for palliation of dysphagia associated with lower third oesophageal carcinoma. Gut. 52:2003;922-926
37. Christie NA, Buenaventura PO, Fernando HC, et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann Thorac Surg 2001; 71: 1797-801; discussion 1801-02.
38. Vakil N, Morris AI, Marcon N, et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am J Gastroenterol. 96:2001;1791-1796
39. Blazeby JM, Farndon JR, Donovan J, Alderson D. A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma. Cancer. 88:2000;1781-1787